Correlation Between Opus Magnum and Ventana Biotech

Can any of the company-specific risk be diversified away by investing in both Opus Magnum and Ventana Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opus Magnum and Ventana Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Opus Magnum Ameris and Ventana Biotech, you can compare the effects of market volatilities on Opus Magnum and Ventana Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opus Magnum with a short position of Ventana Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opus Magnum and Ventana Biotech.

Diversification Opportunities for Opus Magnum and Ventana Biotech

0.0

Correlation Coefficient

Opus Magnum  Ventana Biotech

Pay attention - limited upside

The 3 months correlation between Opus and Ventana is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Opus Magnum Ameris and Ventana Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventana Biotech and Opus Magnum is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opus Magnum Ameris are associated (or correlated) with Ventana Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventana Biotech has no effect on the direction of Opus Magnum i.e., Opus Magnum and Ventana Biotech go up and down completely randomly.

Pair Corralation between Opus Magnum and Ventana Biotech

If you would invest  0.21  in Ventana Biotech on September 15, 2024 and sell it today you would lose (0.07) from holding Ventana Biotech or give up 33.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Opus Magnum Ameris  vs.  Ventana Biotech

Opus Magnum Ameris

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Opus Magnum Ameris has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Opus Magnum is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Ventana Biotech

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ventana Biotech are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ventana Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Opus Magnum and Ventana Biotech

The main advantage of trading using opposite Opus Magnum and Ventana Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opus Magnum position performs unexpectedly, Ventana Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventana Biotech will offset losses from the drop in Ventana Biotech's long position.

The idea behind Opus Magnum Ameris and Ventana Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.